Breaking News

healthcare

93rd Vifor Pharma Group Annual General Meeting

May 6, 2021

Regulatory News: At today’s 93rd Annual General Meeting of Vifor Pharma Ltd., shareholders approved all proposed resolutions put forward by......

Continue Reading >

Smiths Medical and Ivenix Partner to Revolutionize Infusion Management with First-Ever Comprehensive Suite of Infusion Solutions in US Healthcare Market

May 5, 2021

Smiths Medical, a global medical device leader, today announced it has formed an exclusive partnership with Ivenix, Inc. that positions the companies......

Continue Reading >

Study Investigates the Ability of Masimo PVi® to Predict Preload Responsiveness in Patients On Nasal High-Flow Therapy

May 3, 2021

Masimo (NASDAQ: MASI) announced today the findings of a study published in the Journal of Applied Physiology in which Dr. Marina García-de-Acilu......

Continue Reading >

Moderna gets WHO approval for Covid vaccine emergency use

May 2, 2021

The World Health Organisation has listed the Moderna Covid-19 vaccine (mRNA 1273) for emergency use, thus making it the fifth vaccine to receive......

Continue Reading >

VFMCRP announces positive results of phase-III clinical trial of Velphoro® in China

April 30, 2021

Regulatory News: Vifor Fresenius Medical Care Renal Pharma (VFMCRP) today announced positive results from a phase-III study in China (PA-CL-CHINA-01),......

Continue Reading >

Takeda Manufacturing Facilities in Japan and Ireland Recognized With Category Awards for 2021 Facilities of the Year

April 29, 2021

  • Both Awards, Issued by the International Society for Pharmaceutical Engineering...

    Continue Reading >

Hikma and Melinta Therapeutics sign exclusive licensing agreement for two novel anti-infectives for the Middle East and North Africa region

April 29, 2021

Hikma Pharmaceuticals PLC (Hikma) and Melinta Therapeutics (Melinta) today announced they have entered into an exclusive licensing agreement for......

Continue Reading >

Vifor Pharma and Angion announce completion of enrollment in phase-II study of ANG-3777 for cardiac-surgery associated acute kidney injury

April 29, 2021

Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210428005922/en/ Vifor......

Continue Reading >

First patient enrolled in CARE-HK in HF to evaluate role of Veltassa® (patiromer) in enabling RAASi treatment

April 28, 2021

  • CARE-HK in heart failure (HF) is the first global registry of around 5,000...

    Continue Reading >

Takeda Announces U.S. FDA Grants Priority Review for New Drug Application for Mobocertinib (TAK-788) as a Treatment for EGFR Exon20 Insertion+ Metastatic Non-Small Cell Lung Cancer

April 28, 2021

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the U.S. Food and Drug Administration (FDA)......

Continue Reading >